Disulfiram Loaded Transdermal Nanoinvasomal Gel Using Carvacrol as Penetration Enhancer
DOI:
https://doi.org/10.31351/vol34iss3pp215-226Keywords:
Nanotechnology, Transdermal delivery, Invasome, Disulfiram, Hyaluronic acidAbstract
Disulfiram (DSF), an FDA-approved pharmaceutical for the management of alcoholism, has demonstrated its efficacy against several kinds of cancer. DSF has limited solubility, fast metabolism, short duration of action, and instability in physiological environments, mostly caused by rapid degradation in the acidic gastric environment, Therefore, a transdermal gel containing disulfiram, which was loaded into invasomes, was developed to improve the stability of DSF and enable its effective distribution to tumor tissues. The optimal invasomal dispersion was developed in the laboratory using a 4:1 ratio of soya-phosphatidylcholine (SPC) to disulfiram, and 1% carvacrol as a penetration enhancer. Furthermore, three invasomal gel formulas (IV-g1, IV-g2, and IV-g3) have been developed using hyaluronic acid (HA) as the gelling agent at concentrations of 2%, 2.5%, and 3%. These formulations are subjected to further in-vitro evaluation to assess their physical appearance, homogeneity, viscosity, spreadability, and in-vitro drug release. Results indicated that the formula (IV-g3) exhibited better homogeneity, consistency, spreadability, and stability and showed a non-Newtonian flow and a drug content (99.6±0.4%). Compared to the DSF-suspension (16%), the IV-g3 showed a much greater release of DSF (90.03%). The ex-vivo skin permeation of rat abdomen skin for IV-g3 was significantly higher (14.72cm2/h ×10-3) than DSF-suspension's (3.44 cm2/h ×10-3) during an entire day. The enhancement ratio (ER) of IV-g3, which measured 4.27, surpassed that of the DSF suspension. The stability study indicated that there were no significant alterations in the characteristics of the formulation. The study successfully formulated a new transdermal gel by utilizing invasomal nanocarriers. This gel successfully promoted the delivery of DSF through the skin. The transdermal delivery approach exhibited improved stability of DSF, better skin permeability, and enhanced the efficacy of disulfiram.
How to Cite
Publication Dates
Received
Revised
Accepted
Published Online First
References
Xu M, Han X, Xiong H, Gao Y, Xu B, Zhu G, Li J. Cancer nanomedicine: emerging strategies and therapeutic potentials. Molecules. 2023 Jun 30;28(13):5145.
Lang X, Wang T, Sun M, Chen X, Liu Y. Advances and applications of chitosan-based nanomaterials as oral delivery carriers: A review. International journal of biological macromolecules. 2020 Jul 1; 154:433-45.
Raviraj V, Pham BT, Kim BJ, Pham NT, Kok LF, Painter N, Delic NC, Jones SK, Hawkett BS, Lyons JG. Non-invasive transdermal delivery of chemotherapeutic molecules in vivo using superparamagnetic iron oxide nanoparticles. Cancer Nanotechnology. 2021 Dec;12(1):1-5.
Jha H, Sahu A, Arora R. Anti-Neoplastic Transdermal Patches: A Novel Approach for Targeted Drug Delivery Using Nanocarriers in Cancer Therapy. Journal of Advanced Scientific Research. 2022 Jun 30;13(05):01-16.
Zhao Z, Ukidve A, Krishnan V, Mitragotri S. Effect of physicochemical and surface properties on in vivo study of drug nanocarriers. Advanced drug delivery reviews. 2019 Mar 15; 143:3-21.
Morales-Cruz M, Delgado Y, Castillo B, Figueroa CM, Molina AM, Torres A, Milián M, Griebenow K. Smart targeting to improve cancer therapeutics. Drug design, development, and therapy. 2019 Oct 30:3753-72.
Bai X, Smith ZL, Wang Y, Butterworth S, Tirella A. Sustained drug release from smart nanoparticles in cancer therapy: A Comprehensive review. Micromachines. 2022 Sep 28;13(10):1623
Fröhlich E. Cellular elimination of nanoparticles. Environmental toxicology and pharmacology. 2016 Sep 1; 46:90-4.
Poon W, Zhang YN, Ouyang B, Kingston BR, Wu JL, Wilhelm S, Chan WC. Elimination pathways of nanoparticles. ACS Nano. 2019 Apr 16;13(5):5785-98.
Babaie S, Del Bakhshayesh AR, Ha JW, Hamishehkar H, Kim KH. Invasome: A novel nanocarrier for transdermal drug delivery. Nanomaterials. 2020 Feb 17;10(2):341.
Biondo NE, Argenta DF, Rauber GS, Vitali L, Caon T. Enhancing the skin permeation of testosterone with natural terpenes. Journal of Drug Delivery Science and Technology. 2022 Nov 1; 77:103911.
Maryam K, Shakeri S, Kiani K. Preparation and in vitro investigation of antigastric cancer activities of carvacrol‐loaded human serum albumin nanoparticles. IET nanobiotechnology. 2015 Oct;9(5):294-9.
Li H, Wang J, Wu C, Wang L, Chen ZS, Cui W. The combination of disulfiram and copper for cancer treatment. Drug discovery today. 2020 Jun 1;25(6):1099-108.
Lu Y, Pan Q, Gao W, Pu Y, Luo K, He B, Gu Z. Leveraging disulfiram to treat cancer: mechanisms of action, delivery strategies, and treatment regimens. Biomaterials. 2022 Feb 1; 281:121335.
Alam MS, Ansari A, Ahsan I, Shafiq‐un‐Nabi S, Md S, Shaik RA, Eid BG, Ahmad MZ, Ahmad J. Topical gel containing Polysiloxanes and hyaluronic acid for skin scar: Formulation design, characterization, and In vivo activity. Journal of Cosmetic Dermatology. 2023 Apr;22(4):1220-32.
Zhang YT, Li Z, Zhang K, Zhang HY, He ZH, Xia Q, Zhao JH, Feng NP. Co-delivery of evodiamine and rutaecarpine in a microemulsion-based hyaluronic acid hydrogel for enhanced analgesic effects on mouse pain models. International journal of pharmaceutics. 2017 Aug 7;528(1-2):100-6.
Zhang Y, Zhang K, Wang Z, Hu H, Jing Q, Li Y, Guo T, Feng N. Transcutol® P/Cremophor® EL/ethyl oleate–formulated microemulsion loaded into a hyaluronic acid-based hydrogel for improved transdermal delivery and biosafety of ibuprofen. AAPS PharmSciTech. 2020 Jan; 21:1-0.
Raheema DA, Kassab HJ. Preparation and in-vitro Evaluation of Secnidazole as Periodontal In-situ Gel for Treatment of Periodontal Disease. Iraqi Journal of Pharmaceutical Sciences. 2022 Dec 23;31(2):50-61.
Thamer AK, Abood AN. Preparation and In vitro Characterization of Aceclofenac Nanosuspension (ACNS) for Enhancement of Percutaneous Absorption using Hydrogel Dosage Form. Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512). 2021 Dec 9;30(2):86-98.
Malik B, Al-Khedairy EB. Formulation and in vitro/in vivo Evaluation of Silymarin Solid Dispersion-Based Topical Gel for Wound Healing. Iraqi Journal of Pharmaceutical Sciences (P-ISSN 1683-3597 E-ISSN 2521-3512). 2023 Nov 1;32(Suppl.):42-53.
Anjum F, Zakir F, Verma D, Aqil M, Singh M, Jain P, Mirza MA, Anwer MK, Iqbal Z. Exploration of nanoethosomal transgel of naproxen sodium for the treatment of arthritis. Current Drug Delivery. 2020 Dec 1;17(10):885-97.
Jiapaer Z, Zhang L, Ma W, Liu H, Li C, Huang W, Shao S. Disulfiram-loaded hollow copper sulfide nanoparticles show anti-tumor effects in preclinical models of colorectal cancer. Biochemical and Biophysical Research Communications. 2022 Dec 20; 635:291-8
Al-Zheery WH, Kamal BA. Formulation and evaluation of fluticasone propionate colon targeted tablet. Int J Pharm Sci Rev Res. 2016 Nov;41(2):322-9.
Abdulqader AA, Rajab NA. Preparation and characterization of Posaconazole as a Nano-micelles using d-α-Tocopheryl polyethylene glycol 1000 succinate (TPGS).
El-Tokhy FS, Abdel-Mottaleb MM, El-Ghany EA, Geneidi AS. Design of long-acting invasomal nanovesicles for improved transdermal permeation and bioavailability of asenapine maleate for the chronic treatment of schizophrenia. International Journal of Pharmaceutics. 2021 Oct 25; 608:121080.
Ahad A, Al-Saleh AA, Al-Mohizea AM, Al-Jenoobi FI, Raish M, Yassin AE, Alam MA. Pharmacodynamic study of eprosartan mesylate-loaded transfersomes Carbopol® gel under Dermaroller® on rats with methylprednisolone acetate-induced hypertension. Biomedicine & Pharmacotherapy. 2017 May 1; 89:177-84.
Toma NM, Abdulrasool AA. Formulation and Evaluation of Montelukast Sodium Nanoparticles for Transdermal Delivery.
Kumari S, Alsaidan OA, Mohanty D, Zafar A, Das S, Gupta JK, Khalid M. Development of Soft Luliconazole Invasomes Gel for Effective Transdermal Delivery: Optimization to In-Vivo Antifungal Activity. Gels. 2023 Aug 3;9(8):626.
Tamer MA, kassab HJ. The development of a brain-targeted mucoadhesive amisulpride-loaded nanostructured lipid carrier. Farmacia. 2023 Sep 1;71(5).
Prasanthi D, K Lakshmi P. Iontophoretic transdermal delivery of finasteride in vesicular invasomal carriers. Pharmaceutical Nanotechnology. 2013 Apr 1;1(2):136-50.
Saadallah MN, Almajidi YQ, Ali A. Binary Ethosomal Gel for Enhanced Transdermal Delivery of Tazarotene: Development, Refinement, in vitro Evaluation, and Skin Penetration Investigations. Al-Rafidain Journal of Medical Sciences (ISSN 2789-3219). 2023 Nov 1;5(1S): S42-50.
Kumar B, Sahoo PK, Manchanda S. Formulation, characterization and ex vivo study of curcumin nano-invasomal gel for enhanced transdermal delivery. OpenNano. 2022 Jul 1; 7:100058.
Alwan RM, Rajab NA. Nanosuspensions of Selexipag: Formulation, Characterization, and In vitro Evaluation. Iraqi Journal of Pharmaceutical Sciences. 2021 Jun 15;30(1):144- 53.
Jaber SA, Sulaiman HT, Rajab NA. Preparation, characterization, and in-vitro diffusion study of different topical flurbiprofen semisolids.
Myburgh J, Liebenberg W, Willers C, Dube A, Gerber M. Investigation and Evaluation of the Transdermal Delivery of Ibuprofen in Various Characterized Nano-Drug Delivery Systems. Pharmaceutics. 2023 Oct 3;15(10):2413.
Lukić, M.; Pantelić, I.; Savić, S.D. Towards Optimal pH of the Skin and Topical Formulations: From the Current State of the Art to Tailored Products. Cosmetics 2021, 8, 69
Moritz HU. Increase in viscosity and its influence on polymerization processes. Chemical Engineering & Technology. 1989;12(1):71-87.
Pund S, Pawar S, Gangurde S, Divate D. Transcutaneous delivery of leflunomide nanoemulgel: Mechanistic investigation into physicomechanical characteristics, in vitro anti-psoriatic and anti-melanoma activity. International journal of pharmaceutics. 2015 Jun 20;487(1-2):148-56.
Noreen S, Pervaiz F, Ashames A, Buabeid M, Fahelelbom K, Shoukat H, Maqbool I, Murtaza G. Optimization of novel naproxen-loaded chitosan/carrageenan nanocarrier-based gel for topical delivery: Ex vivo, histopathological, and in vivo evaluation. Pharmaceuticals. 2021 Jun 11;14(6):557.
Obayes KK, Thomas LM. Development and Characterization of Hyaluronic Acid-Incorporated Thermosensitive Nasal in situ Gel of Meclizine Hydrochloride. Al-Rafidain Journal of Medical Sciences (ISSN 2789-3219). 2024 Jan 24;6(1):97-104.
USP44.United States Pharmacopeia 44, National Formulary 39(USP NF) 2021, disulfiram tablet.
Li H, Liu B, Ao H, Fu J, Wang Y, Feng Y, Guo Y, Wang X. Soybean lecithin stabilizes disulfiram nanosuspensions with a high drug-loading content: remarkably improved antitumor efficacy. Journal of Nanobiotechnology. 2020 Dec; 18:1-1.
Cho KY, Chung TW, Kim BC, Kim MK, Lee JH, Wee WR, Cho CS. Release of ciprofloxacin from poloxamer-graft-hyaluronic acid hydrogels in vitro. International journal of pharmaceutics. 2003 Jul 9;260(1):83-91.
El-Aassar MR, El Fawal GF, Kamoun EA, Fouda MM. Controlled drug release from cross-linked κ-carrageenan/hyaluronic acid membranes. International Journal of Biological Macromolecules. 2015 Jun 1; 77:322-9
Tyukova VS, Kedik SA, Panov AV, Zhavoronok ES, Mendeleev DI, Senchikhin IN, Fursova AZ, Rumyantseva YV, Kolosova NG. Synthesis of a Disulfiram Inclusion Complex with Hydroxypropyl-β-Cyclodextrin and Its Effect on Cataract Development in Rats. Pharmaceutical Chemistry Journal. 2020 Mar; 53:1158-63.
Zhang C, Xu T, Zhang D, He W, Wang S, Jiang T. Disulfiram thermosensitive in-situ gel based on solid dispersion for cataract. Asian journal of pharmaceutical sciences. 2018 Nov 1;13(6):527-35.
Asghar Z, Jamshaid T, Sajid-ur-Rehman M, Jamshaid U, Gad HA. Novel Transethosomal Gel Containing Miconazole Nitrate; Development, Characterization, and Enhanced Antifungal Activity. Pharmaceutics. 2023 Oct 27;15(11):2537.
Salih O, Muhammed E. Preparation, Evaluation, and Histopathological Studies of Ondansetron-Loaded Invasomes Transdermal Gel.
Sahu AN, Mohapatra D, Acharya PC. Nanovesicular ultra flexible invasomes and invasomal gel for transdermal delivery of phytopharmaceuticals. Nanomedicine. 2024 Apr 1;19(9):737-40.
Shreya AB, Managuli RS, Menon J, Kondapalli L, Hegde AR, Avadhani K, Shetty PK, Amirthalingam M, Kalthur G, Mutalik S. Nano-transfersomal formulations for transdermal delivery of asenapine maleate: in vitro and in vivo performance evaluations. Journal of liposome research. 2016 Jul 2;26(3):221-32.
Vidya K, Lakshmi PK. Cytotoxic effect of transdermal invasomal anastrozole gel on MCF-7 breast cancer cell line. Journal of Applied Pharmaceutical Science. 2019 Mar 29;9(3):050-8.
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Iraqi Journal of Pharmaceutical Sciences

This work is licensed under a Creative Commons Attribution 4.0 International License.